Skip to main content
. Author manuscript; available in PMC: 2020 Sep 1.
Published in final edited form as: Clin Gastroenterol Hepatol. 2018 Nov 29;17(10):2000–2007.e3. doi: 10.1016/j.cgh.2018.11.051

Table 2.

Patient clinical characteristics. All categories are statistically significant at p<0.001 compared controls.

Control
N=599,983		 DOAC
N=1590		 Warfarin
N=3471		 Clopidogrel
N=6443
CCI Score, mean (SD) 0.8 (0.5) 1.7 (2.1) 1.8 (1.7) 1.9 (1.7)
Comorbidities
AF, n (%) 11,322 (1.9%) 1,332 (83.8%) 2,231 (64.3%) 503 (7.8%)
CVA, n (%) 33,094 (5.5%) 347 (21.8%) 704 (20.3%) 2,162 (33.6%)
VTE, n (%) 189 (0.03%) 19 (1.2%) 84 (2.4%) 16 (0.3%)
MI, n (%) 8257 (1.4%) 137 (8.6%) 281 (8.1%) 1504 (23.3%)
PAD, n (%) 37,099 (6.2%) 1333 (20.9%) 750 (21.6%) 2,023 (31.4%)
GIB, n (%) 59,011 (9.8%) 261 (16.4%) 497 (14.3%) 933 (14.5%)
CHADS2 Score, mean
(SD)		 0.03 (0.33) 1.9 (1.4) 1.6 (1.6) 0.2 (0.8)
CHA2DS2VASc, mean
(SD)		 0.06 (0.5) 3.0 (2.1) 2.5 (2.3) 0.3 (1.2)
Bridge Anticoagulation,
n (%)		 0 (0%) 26 (1.6%) 394 (11.4%) 21 (0.3%)
EMR, n (%) 28,323 (4.7%) 91 (5.7%) 208 (6.0%) 6351 (5.5%)

CCI, Charlson comorbidity index; EMR, endoscopic mucosal resection; SD, standard deviation;